And though drugs that have some effect on Alzheimer’s disease, dementia’s most common manifestation, have recently been assessed in America and Britain, not everyone is convinced.
A research team has discovered intricate molecular mechanisms driving the RNA processing defects that lead to Huntington's disease and link HD with other neurodegenerative disorders such as ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...